In China gene-editing trial, 2 children improved, 1 died and 1 withdrew

Four seriously ill Chinese boys who would almost certainly have died in their twenties from a rare inherited disease received the same highly anticipated gene-editing drug. More than a year later, a set of cruel and contradictory data emerged. Two boys gained the strength to walk farther. One boy showed no improveme…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.